Approval · Notice of Compliance 20174 · 2017
VARIZIG: Notice of Compliance 20174
Issued December 19, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20174
- Date
- December 19, 2017
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification number (din)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VARIZIG | 02442183 | Marketed |
Medicinal ingredients
- VARICELLA-ZOSTER IMMUNE GLOBULIN HUMAN 125 UNIT per VIAL